Human Molecular Genetics, 1999, Vol. 8, No. 9 1791-1798
© 1999 Oxford University Press
Altered spacing of promoter elements due to the dodecamer repeat expansion contributes to reduced expression of the cystatin B gene in EPM1
1Division of Medical Genetics, University of Geneva Medical School, 1 rue Michel-Servet, 1211 Geneva 4, Switzerland and 2Cantonal Hospital of Geneva, Geneva, Switzerland
Progressive myoclonus epilepsy of the Unverricht–Lundborg type (EPM1; MIM 254800) is an autosomal recessive disorder characterized by seizures, myoclonus and progression to cerebellar ataxia. EPM1 arises due to mutations in the cystatin B (CSTB) gene which encodes a cysteine proteinase inhibitor. Only a minority of EPM1 alleles carry point mutations, while the majority contain large expansions of the dodecamer CCCCGCCCCGCG repeat which is present at two to three copies in normal individuals. The dodecamer repeat is located in the 5" flanking region of the CSTB gene, presumably in its promoter. The pathological repeat expansion results in a reduction in CSTB mRNA, which may be cell specific. To elucidate the mechanism of this reduction of gene expression, we have studied the putative CSTB promoter in vitro. A 3.8 kb fragment, containing the putative promoter with a 600 bp repeat expansion, showed a 2- to 4-fold reduction in luciferase activity compared with an identical fragment with a normal repeat; this reduction was observed only in certain cell types. Introduction of heterologous DNA fragments of 730 and 1000 bp into the normal promoter, instead of the repeat expansion, showed similarly reduced activity. Terminal deletions of the promoter implicate a putative AP-1 binding site, upstream of the repeat, in CSTB transcription activation. We propose that a novel mechanism of pathogenesis, the altering of the spacing of transcription factor binding sites from each other and/or the transcription initiation site due to repeat expansion, is among the causes of reduction in CSTB expression and thus EPM1.
+ Present address: School of Biochemistry, University of Birmingham, Birmingham, UK
§ To whom correspondence should be addressed at: Division of Medical Genetics, University of Geneva Medical School, 1 rue Michel-Servet, 1211 Geneva 4, Switzerland. Tel: +41 22 702 5707; Fax: +41 22 702 5706; Email: stylianos.antonarakis{at}medecine.unige.ch
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Usdin The biological effects of simple tandem repeats: Lessons from the repeat expansion diseases Genome Res., July 1, 2008; 18(7): 1011 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. I. Richards Dynamic mutations: a decade of unstable expanded repeats in human genetic disease Hum. Mol. Genet., October 1, 2001; 10(20): 2187 - 2194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mazarib, L. Xiong, M.Y. Neufeld, M. Birnbaum, A.D. Korczyn, M. Pandolfo, and S.F. Berkovic Unverricht-Lundborg disease in a five-generation Arab family: Instability of dodecamer repeats Neurology, September 25, 2001; 57(6): 1050 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Johnson Two Expanded Repeats in the Same Patient: An Effect on Phenotype? Arch Neurol, August 1, 2000; 57(8): 1110 - 1112. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sarafova and G. Siu Precise arrangement of factor-binding sites is required for murine CD4 promoter function Nucleic Acids Res., July 15, 2000; 28(14): 2664 - 2671. [Abstract] [Full Text] [PDF]
|
|